SAN

74.115

-4.79%↓

SRT3

223.85

+3.01%↑

ORNBV.FI

68.5

+3.4%↑

SAN

74.115

-4.79%↓

SRT3

223.85

+3.01%↑

ORNBV.FI

68.5

+3.4%↑

SAN

74.115

-4.79%↓

SRT3

223.85

+3.01%↑

ORNBV.FI

68.5

+3.4%↑

SAN

74.115

-4.79%↓

SRT3

223.85

+3.01%↑

ORNBV.FI

68.5

+3.4%↑

SAN

74.115

-4.79%↓

SRT3

223.85

+3.01%↑

ORNBV.FI

68.5

+3.4%↑

Home・Akciju saraksts・Siemens Healthineers AG

Siemens Healthineers AG

Slēgts

SektorsVeselības aprūpe

34.62 2.24

Pirkt Pārdot

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

34.51

Max

34.62

Galvenie mērījumi
By Trading Economics
Ienākumi	-138M 450M
Pārdošana	-920M 5.4B
P/E Sektora vidējais	18.82 67.147
EPS	0.4
Dividenžu ienesīgums	2.82
Peļņas marža	8.33
Darbinieki	73,800
EBITDA	-198M 998M

Rekomendācijas
By TipRanks
Rekomendācijas	Pirkt
Prognoze 12 mēnešiem	+47.41% upside

Dividendes
By Dow Jones
Dividenžu ienesīgums Sektora vidējais	2.82% 2.36%
Nākamie ieņēmumi	2026. g. 7. maijs

Tirgus statistika
By TradingEconomics
Tirgus kapitalizācija	-7.8B 40B
Iepriekšējā atvēršanas cena	32.38
Iepriekšējā slēgšanas cena	34.62

Ziņu noskaņojums

By Acuity

25%

75%

72 / 347 Rangs Healthcare

Tehniskais rādītājs

By Trading Central

Pārliecība

Bearish Evidence

45.88 / 46.84 Atbalsts un pretestība

Siemens Healthineers AG Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2026. g. 5. febr. 06:38 UTC

Peļņas

Siemens Healthineers Core Businesses Offset Currency, Tariff Challenges

2026. g. 14. apr. 17:00 UTC

Iegādes, apvienošanās, pārņemšana

This Healthcare Stock Is Rising 69%. It's Getting Bought Out for a Big Premium. -- Barrons.com

2026. g. 5. febr. 08:02 UTC

Tirgus saruna

Peļņas

Siemens Healthineers Has Bright Growth Prospects Due to Imaging Demand -- Market Talk

2026. g. 5. febr. 06:00 UTC

Peļņas

Siemens Healthineers Expects 2026 Revenue Growth of Between 5% to 6%

2026. g. 5. febr. 06:00 UTC

Peļņas

Siemens Healthineers 1Q Adjusted Basic Earnings Per Share EUR0.49

2026. g. 5. febr. 06:00 UTC

Peļņas

Analysts Saw Siemens Healthineers 1Q Adjusted EBIT at EUR785M

2026. g. 5. febr. 06:00 UTC

Peļņas

Analysts Saw Siemens Healthineers 1Q Revenue at EUR5.44B

2026. g. 5. febr. 06:00 UTC

Peļņas

Siemens Healthineers Backs 2026 View

2026. g. 5. febr. 06:00 UTC

Peļņas

Siemens Healthineers 1Q Adjusted EBIT EUR809M

2026. g. 5. febr. 06:00 UTC

Peļņas

Analysts Saw Siemens Healthineers 1Q Net Profit at EUR418M

2026. g. 5. febr. 06:00 UTC

Peļņas

Siemens Healthineers 1Q Rev EUR5.40B

2026. g. 5. febr. 06:00 UTC

Peļņas

Siemens Healthineers: Overall 1Q Comparable Revenue Growth 3.8%

2026. g. 5. febr. 06:00 UTC

Peļņas

Siemens Healthineers 1Q Net Pft EUR449M

2025. g. 4. dec. 09:53 UTC

Tirgus saruna

Siemens Healthineers Shares Likely to Take Hit as Siemens AG Plans to Reduce Stake -- Market Talk

2025. g. 13. nov. 10:19 UTC

Karstas akcijas

Stocks to Watch Thursday: Cisco, Disney, Applied Materials -- WSJ

2025. g. 13. nov. 06:00 UTC

Peļņas

Siemens: Analysts Saw 4Q Profit From Industrial Business Margin at 15.9%

2025. g. 13. nov. 06:00 UTC

Peļņas

Siemens Issues FY26 View

2025. g. 13. nov. 06:00 UTC

Peļņas

Siemens 4Q Profit From Industrial Business Margin 15.3%

2025. g. 13. nov. 06:00 UTC

Peļņas

Siemens 4Q Net Pft EUR1.62B

2025. g. 13. nov. 06:00 UTC

Peļņas

Siemens Targets FY26 Comparable Revenue Growth in Range of 6% to 8%

2025. g. 13. nov. 06:00 UTC

Peļņas

Siemens 4Q EPS EUR2.07

2025. g. 13. nov. 06:00 UTC

Peļņas

Siemens: Analysts Saw 4Q Profit From Industrial Business at EUR3.32B

2025. g. 13. nov. 06:00 UTC

Peļņas

Siemens: Analysts Saw 4Q Orders at EUR21.92B

2025. g. 13. nov. 06:00 UTC

Peļņas

Siemens: EUR1B Investment to Scale AI Over Next Three Years

2025. g. 13. nov. 06:00 UTC

Peļņas

Siemens: Ambition to Double Digital Business Revenue by 2030

2025. g. 13. nov. 06:00 UTC

Peļņas

Siemens Assumes Global Economic Environment Will Stabilize

2025. g. 13. nov. 06:00 UTC

Peļņas

Siemens Raises Mid-Term Revenue Growth Ambition to a Range of 6% to 9%

2025. g. 13. nov. 06:00 UTC

Peļņas

Siemens Raises Dividend to EUR5.35 Vs EUR5.20

2025. g. 13. nov. 06:00 UTC

Peļņas

Siemens 4Q Profit From Industrial Business EUR3.19B

2025. g. 13. nov. 06:00 UTC

Peļņas

Siemens: Analysts Saw 4Q Revenue at EUR21.43B

Salīdzinājums

Cenas izmaiņa

Siemens Healthineers AG Prognoze

Cenas mērķis

By TipRanks

47.41% augšup

Prognoze 12 mēnešiem

Vidējais 51.402 EUR 47.41%

Augstākais 61.3 EUR

Zemākais 41 EUR

Pamatojoties uz 13 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi Siemens Healthineers AG — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt

13 ratings

Pirkt

Turēt

Pārdot

Pamatojoties uz 13 analītiķiem, kas pēdējo 3 mēnešu laikā snieguši akciju vērtējumus instrumentam Siemens Healthineers AG — pēdējo 3 mēnešu laikā.

Tehniskais rādītājs

By Trading Central

45.88 / 46.84Atbalsts un pretestība

Recent bearish events outweigh bullish events.

All events are bearish.

Noskaņojums

By Acuity

72 / 347 Rangs Veselības aprūpe

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

Par Siemens Healthineers AG

Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and sells a range of diagnostic and therapeutic products and services to healthcare providers worldwide. It operates through four segments: Imaging, Diagnostics, Varian, and Advanced Therapies. The Imaging segment provides magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging, and ultrasound systems. Its Diagnostics segment offers in-vitro diagnostic products and services to healthcare providers in laboratory and point-of-care diagnostics; and workflow solutions for laboratories and informatics products. The Varian segment provides cancer care technologies, solutions, and services to oncology departments in hospitals and clinics; and technology-enabled optimized workflows, clinical services, and digital solutions and applications for managing treatment and therapy. Its Advanced Therapies segment offers products that are designed to support image-guided minimally invasive treatments in various areas, such as cardiology, interventional radiology, and surgery; and angiography systems and mobile C-arms. It offers essential technical customer service, such as maintenance and repair; medical equipment performance management; training; clinical education and e-learning; planning and design; financing; asset management; and managed departmental services for laboratories and healthcare facilities, as well as digital healthhcare consulting, products, and services. The company was incorporated in 2017 and is headquartered in Forchheim, Germany. Siemens Healthineers AG operates as a subsidiary of Siemens Aktiengesellschaft.